Livforsakringsbolaget Skandia, Omsesidigt Zoetis Inc. Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $1.72 Billion
- Q3 2024
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Zoetis Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 2,930 shares of ZTS stock, worth $531,267. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,930
Previous 719
307.51%
Holding current value
$531,267
Previous $124,000
361.29%
% of portfolio
0.03%
Previous 0.01%
Shares
19 transactions
Others Institutions Holding ZTS
# of Institutions
1,921Shares Held
424MCall Options Held
1.15MPut Options Held
1.2M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.47 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.68 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.7MShares$3.57 Billion0.15% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16.2MShares$2.93 Billion2.53% of portfolio
-
Bank Of America Corp Charlotte, NC15.1MShares$2.74 Billion0.23% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $84.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...